Search

everythinglearnresearchcommunity

for

Search:↓

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Tissue engineering advancements are improving skin substitutes for better burn treatment.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

New regenerative therapies show promise for treating hair loss.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Stem cell therapy improves healing and reduces pain in cutaneous radiation syndrome.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

New techniques and materials improve sternum reconstruction and patient quality of life.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Platelet concentrates are useful for tissue repair in medicine and dentistry, with L-PRF showing promising results in various treatments.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

The review says that stem cells are beneficial for making skin replacements.

Entospletinib effectively prevents eye and skin GVHD in mice.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Living Skin Equivalent transplantation helps heal ischemic non-healing wounds.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.